Himax's $80 Million Asset Sale: A Cash Infusion That Couldn't Stem the Bleeding

Related Articles

Is Stem, Inc. (STEM) Finally Turning the Corner with its AI-Driven Energy Solutions

2 months ago

Zentek's Capital Infusion: What Does the C$15 Million Offering Mean

2 months ago

Is Himax Technologies (HIMX) Currently Overvalued

1 months ago

Is ConocoPhillips' Permian Asset Sale a Smart Strategic Move

4 months ago

Category

You may also like

Stock News•1 week ago

Himax Technologies, Inc. Announces Proposed Disposal of Investment in Equity-Method Investee

Himax's equity-method investee will be acquired for $80M in cash, subject to working capital adjustments. The disposal could generate a significant gain for Himax, though the exact impact depends on i...

HIMX

Share

Stock News•1 months ago

Venu Holding: Cash Problems Are Still Evident Despite Large Capital Raises

Venu Holding Corp reported widening Q1 2026 losses as revenue grew only 11% YoY. Despite a $104M capital raise, the company’s cash position increased by just $15M due to heavy PP&E spending and rising...

VENU

Share

Crypto News•1 months ago

Canaan Bleeds $88.7M in Q1 as Bitcoin Slump Crushes Mining Hardware Sales

Canaan reported a $88.7 million net loss for Q1, driven by a sharp decline in mining hardware sales and a $25 million inventory write-down. The results highlight significant margin pressure amid a bro...

BTCUSD

Share

News•2 months ago

Semiconductor Stocks Are Sucking The Lifeblood Out Of U.S. Big Tech Companies

Hyperscalers including Meta, Amazon, and Oracle face mounting balance sheet risks as they issue debt to fund AI-driven capital expenditures. This aggressive spending cycle is fueling semiconductor sto...

Share